Midland, MI, United States of America

Matthew LeBaron

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Dow Global Technolgoies LLC. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Matthew LeBaron

Introduction

Matthew LeBaron is an accomplished inventor based in Midland, MI (US). He has made significant contributions to the field of science and technology, particularly in the area of inducing caspase activity. With a total of 3 patents to his name, LeBaron continues to push the boundaries of innovation.

Latest Patents

LeBaron's latest patents focus on methods of inducing caspase activity. One of his notable inventions involves a treatment compound represented by a specific formula, where R is selected from hydrogen or an alkyl group having from 1 to about 16 carbon atoms. The methods include contacting a cell with this treatment compound, which has a number average molecular weight ranging from 10,100 to 2,000,000 g/mol. Another patent also addresses methods of inducing caspase activity, utilizing a random copolymer as the treatment compound.

Career Highlights

Matthew LeBaron is currently employed at Dow Global Technologies LLC, where he applies his expertise in innovative research and development. His work has contributed to advancements in biochemistry and cellular processes, showcasing his commitment to scientific progress.

Collaborations

LeBaron collaborates with talented individuals such as Caroline Woelfle-Gupta and Daniel Wilson, enhancing the innovative environment at Dow Global Technologies LLC.

Conclusion

Matthew LeBaron exemplifies the spirit of innovation through his patents and contributions to science. His work in inducing caspase activity reflects his dedication to advancing technology and improving our understanding of cellular processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…